Search Results 131-140 of 921 for HTX BacklinkAZ

  1. Hematology - Clinical trials

    Proton beam radiation therapy is one of the treatments for men with prostate cancer who have localized disease. The benefit of the combination with androgen ...

  2. A Study to Evaluate Ruxolitinib for the Treatment of Graft-Versus-Host Disease Following Allogeneic Hematopoietic Stem Cell Transplant - Mayo Clinic

    A Study to Evaluate Ruxolitinib for the Treatment of Graft-Versus-Host Disease Following Allogeneic Hematopoietic Stem Cell Transplant · Overview · Participation ...

  3. Hereditary hemorrhagic telangiectasia - Doctors and departments - Mayo Clinic

    This inherited blood vessel condition can cause bad nosebleeds, strokes, bleeding in the digestive tract and anemia.

  4. Hereditary hemorrhagic telangiectasia - Doctors and departments - Mayo Clinic

    This inherited blood vessel condition can cause bad nosebleeds, strokes, bleeding in the digestive tract and anemia.

  5. Hodgkin Clinical Trials - Mayo Clinic Research

    This phase I trial studies the side effects and the best dose of everolimus when given together with brentuximab vedotin in treating patients with Hodgkin ...

  6. Hereditary hemorrhagic telangiectasia - Doctors and departments - Mayo Clinic

    This inherited blood vessel condition can cause bad nosebleeds, strokes, bleeding in the digestive tract and anemia.

  7. Testing of Real-Time Diagnostic Platform (HPView) for the Detection of High-risk HPV Strains in Urine - Mayo Clinic

    Participant eligibility includes age, gender, type and stage of disease, and previous treatments or health concerns. Guidelines differ from study to study, and ...

  8. Phase 1-2 Study of ADXS11-001 or MEDI4736 Alone or Combo In Cervical or HPV+ Head & Neck Cancer - Mayo Clinic

    About this study. Part A: (ADXS11-001 + MEDI4736 Combination Therapy) will determine the safety and tolerability of the combination and to identify a RP2D.

  9. A Phase Ⅲ Study Of Rilvegostomig In Combination With Fluoropyrimidine And Trastuzumab Deruxtecan As The First-line Treatment For HER2-positive Gastric Cancer - Mayo Clinic

    A Phase Ⅲ Study Of Rilvegostomig In Combination With Fluoropyrimidine And Trastuzumab Deruxtecan As The First-line Treatment For HER2-positive Gastric Cancer.

  10. Clinical trials - Lung Cancer Program

    At Mayo Clinic, experts provide personalized, innovative care for people with a wide range of thoracic cancers, including lung, mesothelioma and others.